anti-ATP synthase, H+ transportingF0 complex, subunit G antibody product blog
Tags: Antibody; Polyclonal Antibody; ATP synthase, H+ transportingF0 complex, subunit G; anti-ATP synthase, H+ transportingF0 complex, subunit G antibody;
The ATP synthase, H+ transportingF0 complex, subunit G n/a (Catalog #MBS716390) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Rabbit anti-human ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G polyclonal Antibody reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s ATP synthase, H+ transportingF0 complex, subunit G can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC). Researchers should empirically determine the suitability of the ATP synthase, H+ transportingF0 complex, subunit G n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Human ATP5L. Storage Buffer: PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. -20 degree C, Avoid freeze / thaw cycles.
Santa Cruz Alternative: Potential replacement for Santa Cruz Biotechnology antibody catalog# sc-86077. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing ATP synthase, H+ transportingF0 complex, subunit G are readily searchable from our website. Different antibodies against the same target such as ATP synthase, H+ transportingF0 complex, subunit G may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.